Clinical Trial Update: D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study evaluating D-serine for negative symptoms and cognitive deficits in schizophrenia, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: Yale University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-05-10